期刊文献+

突变型p53、VEGF在肺癌中的表达与预后的关系 被引量:5

Relationship Between Prognosis and Expressions of Mutant p53 and VEGF in Lung Cancer
下载PDF
导出
摘要 肺癌的发生、转移和预后与突变型p53、VEGF表达密切相关。突变型P53、VEGF在肺癌组织中高表达,阳性表达明显高于正常的肺组织,两者可以作为评估肺癌生物学行为和预后的指标。突变型P53与VEGF在肺癌中表达有相关性,在促进肺癌新生血管形成的机制中可能存在协同作用。 The expressions of mtp53 and VEGF were closely related to the development,metastasls and prognosis of lung cancer, and higher in the lung cancer tissues than in normal lung tissues. They may play an important role in the behavior and biology and prognosis of lung cancer patients and be served as marker to assess prognosis of lung cancer. Mutant p.53 and VEGF expressions in lung cancer have a interrelationship and they have synergies in promoting angiogenesis in the lung cancer.
出处 《解剖科学进展》 CAS 2007年第1期79-82,共4页 Progress of Anatomical Sciences
基金 山东省教育厅资助基金(J04E03)
  • 相关文献

参考文献6

二级参考文献30

  • 1[1]Ferrara N,Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells[J].Biochem Biophys Res Commun,1989,161(2):851-858.
  • 2[2]Berkman RA,Merrill MJ,Reinhold WC,et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms[J].J Clin Invest,1993,91(1):153-159.
  • 3[3]Liotta LA,Stracke ML. Tumor invasion and metastasis:Biochemical mechanisms[A].Lippman ME,Dickson RB,eds.Breast Cancer:Cellular and Molecular Biology[C].Boston:Kulmer Academic Publishers,1998.223-238.
  • 4Mounain C F. Revisions in the international system for staging lung cancer[J]. Chest, 1997,111(6):1710-1717.
  • 5Hiyoshi H, Matsuno Y, Kato H, et al. Clinicopathological significance of nuclear accumulation of tumor suppressor gene p53 product in primary lung cancer[J]. Jpn J Cancer Res, 1992,83 (1): 101-106.
  • 6Kannan K, Amariglio N, Rechavi G, et al. DNA microarrays identification of primary and secondary target genes regulated by P53[J]. Oncogene, 2001,20 (18): 2225-2234.
  • 7Wistuba U, Gazdar A F, Minna J D. Molocular genetics of small cell lung carcinoma[J]. Semin Oncol,2001,28 (2 Suppl4): 3-13.
  • 8Niklinski J, Niklinska W, Chyczewski L, et al. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications[J]. Eur J Cancer Prev, 2001,10(3): 213-226.
  • 9Marchetti A, Buttitta F, Merlo G, et al. P53 alteration in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymphnodes[J]. Cancer Res, 1993,53(12):2846-2851.
  • 10Anderson M L, Spandidos D A. Oncogenes and onco-superssor genes in lung cancer[J]. Respir Med, 1993,87(6):413-420.

共引文献91

同被引文献84

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部